Haloxon

This classification denotes an antihelminthic agent with the molecular formula C14H14Cl3O6P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T8KXA37068, chemically known as phosphorsaeure-o,o-di-(2-chlorethyl)-o-(3-chlor-4-mehyl-cumarin-7-yl)ester but generally known as haloxon, which bears US NIH Compound Identifier 9454. European Medicines Agency schedules Haloxon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08011MIG. The term HALOXON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). HALOXON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, HALOXON remains the US FDA Preferred Term for this commodity. Haloxon bears US NLM identifiers UMLS ID C0062110 and NCI Concept Code C75220. SMILES: CLC1C(C2C(OC1=O)CC(OP(=O)(OCCCL)OCCCL)CC2)C.